3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
23
Sarcoma
18
Neoplasms
8
Neoplasm Metastasis
8
Breast Neoplasms
8
Ovarian Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Fallopian Tube Neoplasms
6
Liposarcoma
5
Leiomyosarcoma
5
Hemangiosarcoma
5
Sarcoma, Synovial
4
Neurofibrosarcoma
4
Lung Neoplasms
4
Kidney Neoplasms
4
Histiocytoma, Malignant Fibrous
4
Urinary Bladder Neoplasms
3
Recurrence
3
Prostatic Neoplasms
3
Glioblastoma
3
Thyroid Carcinoma, Anaplastic
2
Small Cell Lung Carcinoma
2
Sarcoma, Alveolar Soft Part
2
Pancreatic Neoplasms
2
Neuroendocrine Tumors
2
Melanoma
2
Gliosarcoma
2
Fibrosarcoma
2
Dermatofibrosarcoma
2
Clear-cell metastatic renal cell carcinoma
2
Interventions
Paclitaxel
19
pembrolizumab
16
Carboplatin
12
Bevacizumab
8
lenvatinib
6
rucaparib
5
Nivolumab
5
Megestrol Acetate
5
Radiation
4
Indocyanine Green
4
Gemcitabine
4
Cisplatin
4
tisotumab vedotin
3
temsirolimus
3
Sirolimus
3
Sentinel Lymph Node Biopsy
3
Magnetic Resonance Spectroscopy
3
Doxorubicin
3
olaparib
2
niraparib
2
ixabepilone
2
iso-sulfan blue
2
irosustat
2
epacadostat
2
durvalumab
2
copanlisib
2
Trastuzumab
2
Taxes
2
Specimen Handling
2
Radiotherapy, Intensity-Modulated
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Endometrial Neoplasms
×
pazopanib
×
Clear all
No trials found.